AU2019377432A1 - Anti-diabetic activity of neem extract and synergistic combinations of urolithins A and B - Google Patents

Anti-diabetic activity of neem extract and synergistic combinations of urolithins A and B Download PDF

Info

Publication number
AU2019377432A1
AU2019377432A1 AU2019377432A AU2019377432A AU2019377432A1 AU 2019377432 A1 AU2019377432 A1 AU 2019377432A1 AU 2019377432 A AU2019377432 A AU 2019377432A AU 2019377432 A AU2019377432 A AU 2019377432A AU 2019377432 A1 AU2019377432 A1 AU 2019377432A1
Authority
AU
Australia
Prior art keywords
aqueous extract
azadirachta indica
weeks
group
individual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2019377432A
Other languages
English (en)
Inventor
Sanyasi R. Kalidindi
Chandan K. Sen
Muruganandam A. Veeraragavan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Natreon Inc
Original Assignee
Natreon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natreon Inc filed Critical Natreon Inc
Publication of AU2019377432A1 publication Critical patent/AU2019377432A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2019377432A 2018-11-05 2019-11-05 Anti-diabetic activity of neem extract and synergistic combinations of urolithins A and B Abandoned AU2019377432A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN201841041788 2018-11-05
IN201841041788 2018-11-05
US16/672,743 2019-11-04
US16/672,743 US20200138892A1 (en) 2018-11-05 2019-11-04 Anti-diabetic activity of neem extract and synergistic combinations of urolithins a and b
PCT/US2019/059774 WO2020097014A1 (en) 2018-11-05 2019-11-05 Anti-diabetic activity of neem extract and synergistic combinations of urolithins a and b

Publications (1)

Publication Number Publication Date
AU2019377432A1 true AU2019377432A1 (en) 2021-06-10

Family

ID=70460249

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2019377432A Abandoned AU2019377432A1 (en) 2018-11-05 2019-11-05 Anti-diabetic activity of neem extract and synergistic combinations of urolithins A and B

Country Status (10)

Country Link
US (1) US20200138892A1 (https=)
EP (1) EP3876968A4 (https=)
JP (1) JP2022536223A (https=)
KR (1) KR20210096121A (https=)
CN (1) CN113226347A (https=)
AU (1) AU2019377432A1 (https=)
BR (1) BR112021008725A2 (https=)
CA (1) CA3118926A1 (https=)
MX (1) MX2021005246A (https=)
WO (1) WO2020097014A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220098228A1 (en) * 2020-09-28 2022-03-31 Natreon, Inc. Methods and compositions for improving the immune system and providing immuno-protection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8206753B2 (en) * 2001-06-20 2012-06-26 Metaproteomics, Llc Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
JP2005325025A (ja) * 2004-05-12 2005-11-24 Green Kanpo Seiyaku Kk 糖尿病予防・治療組成物
WO2006030426A1 (en) * 2004-09-13 2006-03-23 Amcod Limited Herbal compositions for treatment of diabetes

Also Published As

Publication number Publication date
EP3876968A4 (en) 2022-09-14
WO2020097014A1 (en) 2020-05-14
US20200138892A1 (en) 2020-05-07
BR112021008725A2 (pt) 2021-08-03
CA3118926A1 (en) 2020-05-14
KR20210096121A (ko) 2021-08-04
EP3876968A1 (en) 2021-09-15
JP2022536223A (ja) 2022-08-15
CN113226347A (zh) 2021-08-06
MX2021005246A (es) 2021-09-08

Similar Documents

Publication Publication Date Title
Ansori et al. Medicinal properties of Muntingia calabura L.: A Review
Komalasari et al. A Review on the Anti-diabetic Activity of Andrographis paniculata (Burm. f.) Nees based In-vivo Study
Majeed et al. Novel Emblica officinalis extract containing β-glucogallin vs. metformin: a randomized, open-label, comparative efficacy study in newly diagnosed type 2 diabetes mellitus patients with dyslipidemia
Sarbini et al. The effect of rosella (Hibiscus sabdariffa linn) on insulin resistance in patients with type 2 diabetes mellitus: a randomized clinical trial
Shadnoush et al. Effects of supplementation with curcuminoids on serum adipokines in critically ill patients: A randomized double‐blind placebo‐controlled trial
Lim et al. A narrative review of human clinical trials on the impact of phenolic-rich plant extracts on prediabetes and its subgroups
Sadino et al. An evidence-based review of Morinda citrifolia L.(Rubiaceae) fruits on animal models, human studies, and case reports
US10183047B2 (en) Chromium-containing compositions in combination with Phyllanthus emblica and shilajit having synergistic effects for improving endothelial function and cardiovascular health
US20200138892A1 (en) Anti-diabetic activity of neem extract and synergistic combinations of urolithins a and b
Nwaehujor et al. Evaluation of Mallotus oppositifolius Methanol Leaf Extract on the Glycaemia and Lipid Peroxidation in Alloxan‐Induced Diabetic Rats: A Preliminary Study
Dahlquist et al. Clinical application of Momordica charantia (Bitter Melon) for reducing blood sugar in type 2 diabetes mellitus
KR20190051150A (ko) 장수풍뎅이 유충의 추출물을 함유하는 항알레르기성 조성물
US20160015740A1 (en) Chromium-containing compositions for improving endothelial function and cardiovascular health
Firdous et al. Unravelling the role of natural herbs for the management of diabetes mellitus
Nawaz et al. Evaluation of acute and repeated dose toxicity of the polyherbal formulation Linkus syrup in experimental animals
Agnes Exploring the nutritional benefits of medicinal plants in diabetes management
Kausar et al. Health Benefits Of Herbal Nutraceuticals: An Overview
Choi et al. Eriobotrya japonica improves cognitive function in healthy adolescents: a 12-week, randomized double-blind, placebo-controlled clinical trial
Mani et al. A clinical study on Clitoria ternatea tea therapy to manage diabetic distress in people with type 2 diabetes
CN106074753A (zh) 促进胰高血糖素样肽‑1分泌的中药复合物及其制备方法
Yusuf et al. Antidiabetic Properties of Aqueous Leaf and Stem Extracts of Andrographis paniculata on Alloxan Induced Diabetes in Wistar Rats
WO2016186695A1 (en) Synergistic compositions containing chromium with phyllanthus emblica and shilajit for improving endothelial function and cardiovascular health
US9278081B2 (en) Extracts from Eucalyptus camaldulensis for the treatment of hyperglycemia and hypertension
Mani et al. Original Research Article A clinical study on Clitoria ternatea tea therapy to manage diabetic distress in people with type 2 diabetes
Sholehah et al. EFFECT OF COMBINING PHALERIA MACROCARPA AND AVERRHOA BILIMBI L ON FASTING BLOOD GLUCOSE LEVES IN A RAT MODEL OF TYPE 2 DIABETES MELLITUS

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application